financetom
Business
financetom
/
Business
/
Palo Alto Networks' 'Platformization' Strategy Poised for Inflection in Fiscal 2026, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Palo Alto Networks' 'Platformization' Strategy Poised for Inflection in Fiscal 2026, Wedbush Says
Sep 15, 2025 6:17 PM

11:01 AM EDT, 09/15/2025 (MT Newswires) -- Palo Alto Networks' ( PANW ) "platformization" strategy continues to gain traction, potentially reaching an inflection point in fiscal 2026, Wedbush Securities said in a Monday note.

Wedbush said Palo Alto Networks' ( PANW ) planned acquisition of CyberArk Software ( CYBR ) will be a "game changer" for the company as cybersecurity is poised to be a core derivative beneficiary of the artificial intelligence revolution. This positions Palo Alto Networks ( PANW ) to gain from the next wave of tech spending, the investment firm said.

Wedbush added Palo Alto Networks ( PANW ) to its "Best Ideas List," saying it remains one of its favorite cyber security stocks to hold over the next 12 to 18 months.

Analysts reiterated an outperform rating on the stock with a $225 price target.

Shares of Palo Alto Networks ( PANW ) were up 2% in recent Monday trading.

Price: 200.13, Change: +3.84, Percent Change: +1.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Major Trump Media shareholder sells nearly entire stake
Major Trump Media shareholder sells nearly entire stake
Nov 15, 2024
Nov 15 (Reuters) - Trump Media & Technology Group's ( DJT ) key shareholder, ARC Global Investments, has unloaded nearly all its stake in the media company, it said in a regulatory filing on Thursday. ARC and its manager Patrick Orlando now hold about 0.01% stake, down from more than 5% or over 11 million shares in September. Orlando was...
Zillow Group Insider Sold Shares Worth $1,111,609, According to a Recent SEC Filing
Zillow Group Insider Sold Shares Worth $1,111,609, According to a Recent SEC Filing
Nov 15, 2024
05:29 PM EST, 11/15/2024 (MT Newswires) -- Jeremy Wacksman, Director, Chief Executive Officer, on November 13, 2024, sold 15,121 shares in Zillow Group ( ZG ) (Z, ZG) for $1,111,609. Following the Form 4 filing with the SEC, Wacksman has control over a total of 152,542 shares of the company, with 152,542 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1617640/000161764024000130/xslF345X05/wk-form4_1731709245.xml ...
Zillow Group Insider Sold Shares Worth $4,343,507, According to a Recent SEC Filing
Zillow Group Insider Sold Shares Worth $4,343,507, According to a Recent SEC Filing
Nov 15, 2024
05:28 PM EST, 11/15/2024 (MT Newswires) -- David A. Beitel, Chief Technology Officer, on November 13, 2024, sold 59,929 shares in Zillow Group ( ZG ) (Z, ZG) for $4,343,507. Following the Form 4 filing with the SEC, Beitel has control over a total of 165,015 shares of the company, with 165,015 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1617640/000161764024000131/xslF345X05/wk-form4_1731709314.xml ...
Eyenovia to end eye drug study, cut 50% of its workforce
Eyenovia to end eye drug study, cut 50% of its workforce
Nov 15, 2024
(Reuters) -Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce. Shares of the company were down nearly 70% at close of trading on Friday. The drug, a low-dose atropine, was being tested with the company's experimental drug-delivery device, Optejet, as a potential treatment for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved